Boerne, TX, United States of America

Fredrick H Hausheer

This inventor holds 1 USPTO granted patent. Top assignee: Bionumerik Pharmaceuticals, Inc.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fredrick H Hausheer. Retrieved from https://idiyas.com/inventor/fredrick-h-hausheer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fredrick H. Hausheer: Innovator in Pharmaceutical Formulations

Introduction

Fredrick H. Hausheer is a notable inventor based in Boerne, Texas. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of taxane antineoplastic agents. His work is crucial for the development of effective cancer treatments.

Latest Patents

Fredrick holds a patent for "Pharmaceutical formulations of taxanes." This patent focuses on a pharmaceutical formulation of a taxane antineoplastic agent, specifically paclitaxel or docetaxel, or a pharmaceutically acceptable salt thereof, combined with N-methylpyrrolidin-2-one (NMP). The formulation may include other excipients and/or diluents, making it suitable for administration to patients with cancer. He has 1 patent to his name.

Career Highlights

Fredrick is associated with Bionumerik Pharmaceuticals, Inc., where he applies his expertise in pharmaceutical formulations. His work has the potential to improve treatment options for cancer patients, showcasing his commitment to advancing medical science.

Collaborations

Fredrick has collaborated with notable colleagues, including Dhanabalan Murali and Peddaiahgari Seetharamulu. These collaborations enhance the innovative efforts within the pharmaceutical industry.

Conclusion

Fredrick H. Hausheer's contributions to pharmaceutical formulations demonstrate his dedication to improving cancer treatment. His innovative work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…